Stage 4 Bone Cancer Prognosis

Updated at: Jun 28, 2013
Stage 4 Bone Cancer Prognosis

Stage 4 bone cancer prognosis has improved significantly on account of advances in chemotherapy and the discovery of new drugs that fight cancer. Find out how long a person is likely to survive after treatment.

Tilottama Chatterjee
CancerWritten by: Tilottama ChatterjeePublished at: Jun 26, 2013

Stage 4 bone cancer prognosis should begin with the definition of the stage.

Annually, many thousands of people are diagnosed with bone cancer. Malignant tumours that are confined in the bone, is called primary bone cancer. Malignant tumours in other organs spread, or metastasize, to the bone in Stage 4 cancer.

Various types of bone cancer have been categorised depending on the part of the bone where the tumour is localised. Some of them are chordoma, fibrosarcoma, Ewing’s sarcoma, and osteosarcoma etc.

The stage 4 bone cancer prognosisis difficult to predict but we may describe the symptoms below:

  • Tumours of various sizes can be seen some over five centimetres in size.
  • Lymph nodes have been affected by cancer cells
  • Cancer has spread to other organs, which is referred to as secondary cancer
  • Pain and swelling in the bones and joints resulting in loss of movement
  • Susceptibility to fractures, weight loss, tiredness, fever and sweating

Stage 4 bone cancer prognosishas improved significantly on account of advances in chemotherapy and the discovery of new drugs that fight cancer.

The chances of recovery vary according to various factors such as overall fitness of the person, age and mental strength, how far the cancer has spread. It also depends on the size, location; extent the cancer can be removed by surgery, how much of it can be killed by chemotherapy and radiotherapy.

When the tumour is small and localised, 90 per cent of patients live for at least five years. He five- year survival rate decreases to 60 per cent and prognosis becomes poor once the cancer spreads.

Hereditary and genetic factors may influence survival rates and this may vary according to race and sex.

Generally, stage 4 bone cancer prognoses indicates a survival rate of nearly 32% and about 15% cases are diagnosed at this stage. Even though the exact staging information is not available for about 8% of the total bone cancer cases diagnosed, the survival rate for these cases is around 63%.

Of paramount importance is early diagnosis of the disease which gives doctors a chance to choose the correct treatment to combat it. This halts the progress of the cancer to other sites and improves survival chances. Of paramount importance is the patient’s inherent will to survive and take the pains of these treatments in their stride.

In conclusion, stage 4 bone cancer prognosis depends on the nature of the cancer and the extent it has spread to other organs in the body. The patient suffers intense pain, bones and bone joints swell, fractures occur, which renders the person immobile. Other factors that influence survival chances are genetic in nature and race and sex seem to have a bearing on survival chances.

Modern drugs and therapies have improved thestage 4 bone cancer prognosis. Of note is the attempt to shrink tumours with the aid of chemotherapy and well directed radiotherapy after MRI scans and its subsequent removal by surgery. Bone grafts and metal implants have helped patients to have a better quality of life.




All possible measures have been taken to ensure accuracy, reliability, timeliness and authenticity of the information; however does not take any liability for the same. Using any information provided by the website is solely at the viewers’ discretion. In case of any medical exigencies/ persistent health issues, we advise you to seek a qualified medical practitioner before putting to use any advice/tips given by our team or any third party in form of answers/comments on the above mentioned website.

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK